Compugen Reports 22-Percent Slide in Q3 Revenue, Names New CEO | GenomeWeb

NEW YORK, Nov. 2 (GenomeWeb News) - Compugen said today that revenues for the third quarter declined 22 percent while net losses remained flat.

 

The company also said it has named Alex Kotzer president and CEO. He started on Sept. 1.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.